HR17: Heroin Combined with Fentanyl Is Driving Overdose Crisis in U.S.
- Details
- Category: Drug Use and Harm Reduction
- Published on Friday, 30 June 2017 00:00
- Written by Liz Highleyman
New sources of heroin and increasing adulteration with fentanyl and other stronger analogs are contributing to a growing epidemic of opioid overdose deaths in several regions of the U.S., researchers reported at the 25th Harm Reduction International Conference last month in Montreal.
HR17: People May Use Cannabis and Drug Cocktails as a Form of Harm Reduction
- Details
- Category: Drug Use and Harm Reduction
- Published on Friday, 30 June 2017 00:00
- Written by Liz Highleyman
People who use drugs have come up with innovative strategies that help them reduce harm, including using marijuana to decrease crack use and mixing heroin with methamphetamine to moderate the effects of meth or prolong the duration of heroin, according to presentations at the 25th Harm Reduction International Conference last month in Montreal.
HR17: Indonesian Buyers Club Helps People Obtain Generic Hepatitis C Treatment
- Details
- Category: HCV Treatment
- Published on Wednesday, 31 May 2017 00:00
- Written by Liz Highleyman
A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral drugs to treat hepatitis C and is seeing a high cure rate, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.
HR17: Combining Drug Addiction Treatment and Perinatal HIV Prevention Leads to Good Outcomes
- Details
- Category: Pregnancy & HIV MTCT
- Published on Wednesday, 31 May 2017 00:00
- Written by Liz Highleyman
An integrated program offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.
HR17: Hepatitis C Virus Reinfection Is Uncommon After Being Cured with DAAs
- Details
- Category: HCV Treatment
- Published on Thursday, 18 May 2017 00:00
- Written by Liz Highleyman
Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during 3 years of follow-up, researchers reported at the 25th Harm Reduction International Conference this week in Montreal.
Web Design and Development by